BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19499352)

  • 1. Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis.
    Zhang J; Zhuo WL; Zheng Y; Zhang YS
    Med Oncol; 2010 Jun; 27(2):540-6. PubMed ID: 19499352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls.
    Zhuo W; Zhang Y; Xiang Z; Cai L; Chen Z
    J Exp Clin Cancer Res; 2009 Aug; 28(1):115. PubMed ID: 19682377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese.
    Xu B; Xu Z; Cheng G; Min ZC; Mi Y; Zhang ZZ; Tao J; Li PC; Wang ML; Tang JL; Zhang ZD; Zhang W; Wu HF; Feng NH; Hua LX
    Cancer Genet Cytogenet; 2010 Oct; 202(2):76-81. PubMed ID: 20875869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk.
    Li MS; Liu JL; Wu Y; Wang P; Teng H
    Genet Mol Res; 2011 Nov; 10(4):2924-33. PubMed ID: 22179964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
    Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
    Zhou X; Gu Y; Zhang SL
    Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer.
    Salehi Z; Hadavi M
    J Med Virol; 2012 Sep; 84(9):1423-7. PubMed ID: 22825821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
    Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.
    Xu T; Xu ZC; Zou Q; Yu B; Huang XE
    Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
    Jiang N; Pan J; Wang L; Duan YZ
    Tumour Biol; 2013 Feb; 34(1):587-96. PubMed ID: 23192640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
    Lv L; Wang P; Zhou X; Sun B
    Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
    Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
    Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese.
    Suzuki K; Matsui H; Ohtake N; Nakata S; Takei T; Nakazato H; Okugi H; Koike H; Ono Y; Ito K; Kurokawa K; Yamanaka H
    J Biomed Sci; 2003; 10(4):430-5. PubMed ID: 12824702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
    Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
    Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Wang JJ; Zheng Y; Sun L; Wang L; Yu PB; Dong JH; Zhang L; Xu J; Shi W; Ren YC
    Mol Biol Rep; 2011 Nov; 38(8):4847-53. PubMed ID: 21140221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.
    Shen H; Solari A; Wang X; Zhang Z; Xu Y; Wang L; Hu X; Guo J; Wei Q
    Oncol Rep; 2004 May; 11(5):1115-20. PubMed ID: 15069555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer.
    Zhang Q; Ma YY; Wang HJ; Shao CM; Zhang J; Ye ZY
    J Surg Oncol; 2013 Mar; 107(4):360-6. PubMed ID: 22886602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.